Detalles de la búsqueda
1.
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Bone Marrow Transplant;
2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486114
2.
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Blood Cancer J;
14(1): 31, 2024 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38374026
3.
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
Br J Haematol;
204(1): 250-259, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37784256
4.
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Bone Marrow Transplant;
59(1): 101-106, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923831
5.
Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan.
Blood Adv;
8(3): 640-652, 2024 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100431
6.
Oxidation is an underappreciated post-translational modification in the regulation of immune responses associated with changes in phosphorylation.
Front Immunol;
14: 1244431, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37809076
7.
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant;
58(11): 1179-1181, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558780
8.
Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies.
Blood Adv;
7(13): 3297-3306, 2023 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36877784
9.
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Bone Marrow Transplant;
58(4): 386-392, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585459
10.
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.
Acta Oncol;
61(11): 1332-1338, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36214787
11.
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide.
Bone Marrow Transplant;
57(12): 1758-1764, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057732
12.
Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHD.
Transplant Cell Ther;
28(11): 783.e1-783.e10, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964937
13.
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
Clin Lymphoma Myeloma Leuk;
22(1): 34-43, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34456160
14.
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther;
28(3): 169.e1-169.e9, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34954296
15.
A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant;
56(11): 2755-2762, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262141
16.
[Eligibility of patients for CAR T-cell: Expert opinion-based collaborative work by the SFGM-TC]. / Éligibilité des patients aux cellules CAR-T : avis d'experts proposé par la SFGM-TC.
Bull Cancer;
108(7-8): 725-729, 2021.
Artículo
en Francés
| MEDLINE | ID: mdl-33423776
17.
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
Bone Marrow Transplant;
56(4): 883-889, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33191403
18.
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseases.
Blood Adv;
4(24): 6327-6335, 2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33351128
19.
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients.
BMC Cancer;
20(1): 1140, 2020 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234127
20.
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.
Blood Adv;
4(16): 3900-3912, 2020 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32813875